Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VIDI A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 9 of 9

  • Page / 1
Export

Selection :

  • and

ACTION OF 4-PRENYL-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE (DA2370, FENILPRENAZONE) ON THE GLYCOSAMINOGLYCAN FRACTIONS OF INFLAMED RAT PAWS = ACTION DE LA PRENYL-4 DIPHENYL-3,5 PYRAZOLIDINEDIONE (DA2370, PHENYLPRAZONE) SUR LES FRACTIONS DE GLYCOSAMINOGLYCANES DES PATTES ENFLAMMEES DE RATCOPPI G; BONARDI G; VIDI A et al.1973; PHARMACOL. RES. COMMUNIC.; G.B.; DA. 1973; VOL. 5; NO 1; PP. 25-28; BIBL. 6 REF.Serial Issue

NEW METHOD FOR QUANTITATIVE DETERMINATION OF D-DOPA IN LEVO-DOPA SAMPLES = UN NOUVEAU PROCEDE POUR LA DETERMINATION QUANTITATIVE DE LA D-DOPA DANS LES ECHANTILLONS DE LEVODOPAVIDI A; FRANCO C; BONARDI G et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 7; PP. 1130-1131; BIBL. 4REF.Article

EFFECT OF 4-PRENYL-1,2-DIPHENYL 3,5-PYRAZOLIDINEDIONE (DA 2370 FENILPRENAZONE) ON LYSOSOMESCOPPI G; BONARDI G; VIDI A et al.1973; BIOCHEM. PHARMACOL.; G.B.; DA. 1973; VOL. 22; NO 10; PP. 1237-1239; BIBL. 16 REF.Serial Issue

SPECIES DIFFERENCES IN THE METABOLISM OF FEPRAZONE, AN ANTIINFLAMMATORY DRUGGAETANI M; YAMAGUCHI H; VIDI A et al.1979; PHARMACOL. RES. COMMUNIC.; GBR; DA. 1979; VOL. 11; NO 8; PP. 719-730; BIBL. 9 REF.Article

RECTAL ADMINISTRATION OF FEPRAZONE IN HEALTHY VOLUNTEERSFERRARI P; MONTANARI C; SALA P et al.1976; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1976; VOL. 3; NO 2; PP. 339-340; BIBL. 8 REF.Article

Evidence that imipramine activates 5-HT1C receptor functionBORSINI, F; CESANA, R; VIDI, A et al.European journal of pharmacology. 1991, Vol 203, Num 3, pp 359-363, issn 0014-2999Article

Discontinuous oral absorption of cimetropium bromide, a new antispasmodic drugIMBIMBO, B. P; DANIOTTI, S; VIDI, A et al.Journal of pharmaceutical sciences. 1986, Vol 75, Num 7, pp 680-684, issn 0022-3549Article

Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjectsIMBIMBO, B. P; SEIBERLING, M; PEUCKERT, U et al.European journal of clinical pharmacology. 1988, Vol 35, Num 6, pp 673-676, issn 0031-6970Article

Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteersIMBIMBO, B. P; URSO, R; THIEME, G et al.British journal of clinical pharmacology. 1988, Vol 26, Num 4, pp 407-413, issn 0306-5251Article

  • Page / 1